002589 瑞康医药
已收盘 07-19 15:00:00
资讯
新帖
简况
瑞康医药(002589.SZ):烟台慧投完成增持 合计增持263.86万股
智通财经 · 06-24
瑞康医药(002589.SZ):烟台慧投完成增持 合计增持263.86万股
瑞康医药(002589)6月21日主力资金净买入807.33万元
证券之星 · 06-24
瑞康医药(002589)6月21日主力资金净买入807.33万元
瑞康医药最新公告:拟1000万元设合资公司 共建人体肠道微生物功能挖掘及临床应用技术开发基地
证券之星 · 06-14
瑞康医药最新公告:拟1000万元设合资公司 共建人体肠道微生物功能挖掘及临床应用技术开发基地
瑞康医药(002589.SZ)拟与美益添共设合资公司 共建人体肠道微生物相关开发基地
智通财经 · 06-14
瑞康医药(002589.SZ)拟与美益添共设合资公司 共建人体肠道微生物相关开发基地
5月28日瑞康医药现1275万元大宗交易
证券之星 · 05-28
5月28日瑞康医药现1275万元大宗交易
瑞康医药(002589.SZ)2023年度拟每10股派0.13元 6月4日除权除息
智通财经 · 05-27
瑞康医药(002589.SZ)2023年度拟每10股派0.13元 6月4日除权除息
瑞康医药:公司目前无退市风险,公司未来展望详见公司2023年年度报告
证券之星 · 05-24
瑞康医药:公司目前无退市风险,公司未来展望详见公司2023年年度报告
瑞康医药(002589)5月6日主力资金净卖出246.61万元
证券之星 · 05-07
瑞康医药(002589)5月6日主力资金净卖出246.61万元
图解瑞康医药一季报:第一季度单季净利润同比减28.31%
证券之星 · 04-30
图解瑞康医药一季报:第一季度单季净利润同比减28.31%
图解瑞康医药年报:第四季度单季净利润同比增100.06%
证券之星 · 04-30
图解瑞康医药年报:第四季度单季净利润同比增100.06%
瑞康医药(002589.SZ)发布一季度业绩,净利润1516.9万元,下降28.31%
智通财经 · 04-30
瑞康医药(002589.SZ)发布一季度业绩,净利润1516.9万元,下降28.31%
瑞康医药(002589.SZ)收到山东证监局警示函
智通财经网 · 2023-12-29
瑞康医药(002589.SZ)收到山东证监局警示函
公司概况
公司名称:
瑞康医药集团股份有限公司
所属行业:
批发业
上市日期:
2011-06-10
主营业务:
瑞康医药集团股份有限公司的主营业务为药品销售。其主要产品和服务为药品和器械配送、体外诊断、数字医疗、医药物流、中医药。公司目前已发展成一家全国性药品、医疗器械流通行业的领军企业之一,在中国医药商业协会公布的最新一期医药流通企业销售排名第七。对医疗机构直销业务规模在全国民营医疗企业中处于领先地位,IVD业务规模在全国处于领先地位。
发行价格:
20.00
{"stockData":{"symbol":"002589","market":"SZ","secType":"STK","nameCN":"瑞康医药","latestPrice":2.18,"timestamp":1721372610000,"preClose":2.2,"halted":0,"volume":22141204,"delay":0,"floatShares":1364000000,"shares":1505000000,"eps":0.0096,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.02,"latestTime":"07-19 15:00:00","open":2.19,"high":2.22,"low":2.17,"amount":48390000,"amplitude":0.0227,"askPrice":2.19,"askSize":5253,"bidPrice":2.18,"bidSize":1061,"shortable":0,"etf":0,"ttmEps":0.0096,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721611800000},"adr":0,"adjPreClose":2.2,"symbolType":"stock","openAndCloseTimeList":[[1721352600000,1721359800000],[1721365200000,1721372400000]],"highLimit":2.42,"lowLimit":1.98,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1504710471,"pbRate":0.61,"roa":"--","roe":"0.28%","epsLYR":0.0135,"committee":0.00862,"marketValue":3280000000,"floatMarketCap":2974000000,"peRate":227.083323,"changeRate":-0.0091,"turnoverRate":0.0162,"status":1},"requestUrl":"/m/hq/s/002589/wiki","defaultTab":"wiki","newsList":[{"id":"2445073013","title":"瑞康医药(002589.SZ):烟台慧投完成增持 合计增持263.86万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2445073013","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445073013?lang=zh_cn&edition=full","pubTime":"2024-06-24 20:10","pubTimestamp":1719231019,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑞康医药(002589.SZ)公告,公司董事、监事及高管团队成立的烟台慧投投资发展合伙企业(有限合伙)(简称“烟台慧投”)通过深圳证券交易所系统以集中竞价方式累计增持公司股份263.86万股,增持计划已实施完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1139698.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","BK0185","BK0070","BK0197","002589","BK0077","BK0250"],"gpt_icon":0},{"id":"2445093264","title":"瑞康医药(002589)6月21日主力资金净买入807.33万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445093264","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445093264?lang=zh_cn&edition=full","pubTime":"2024-06-24 09:15","pubTimestamp":1719191713,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年6月21日收盘,瑞康医药报收于2.28元,上涨2.24%,换手率0.94%,成交量12.77万手,成交额2893.7万元。融券方面,融券卖出9500.0股,融券偿还1.82万股,融券余量26.05万股,融券余额59.39万元。瑞康医药主营业务:公司主营业务分为药品、疫苗、医疗器械流通服务板块,医疗产业第三方物流板块,医疗信息化服务板块,医疗后勤服务板块,中医药板块,医院经营板块,医疗产业研发生产板块,医疗产业金融板块等八大主体板块。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062400001903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0250","BK0070","002589","BK0132","BK0197","BK0185"],"gpt_icon":0},{"id":"2443401446","title":"瑞康医药最新公告:拟1000万元设合资公司 共建人体肠道微生物功能挖掘及临床应用技术开发基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2443401446","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443401446?lang=zh_cn&edition=full","pubTime":"2024-06-14 18:41","pubTimestamp":1718361669,"startTime":"0","endTime":"0","summary":"瑞康医药公告,公司拟与美益添生物医药(武汉)有限公司共同出资设立合资公司,共建人体肠道微生物功能挖掘及临床应用技术开发基地。合资公司预计总投资额为1000万元。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061400038405.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0185","BK0250","002589","BK0070","BK0077","BK0197"],"gpt_icon":0},{"id":"2443470046","title":"瑞康医药(002589.SZ)拟与美益添共设合资公司 共建人体肠道微生物相关开发基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2443470046","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443470046?lang=zh_cn&edition=full","pubTime":"2024-06-14 18:28","pubTimestamp":1718360900,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑞康医药(002589.SZ)发布公告,公司基于业务拓展和市场深化的战略需求,拟与美益添生物医药(武汉)有限公司(简称“美益添”)共同出资设立合资公司,共建人体肠道微生物功能挖掘及临床应用技术开发基地,将其持有的肠道菌群移植医疗技术授权公司和/或其关联公司在双方约定合作区域和渠道范围内独家开展合作,包括但不限于经销、销售、推广等,以促进医疗机构服务领域与益生菌研发技术的深度融合。合资公司预计总投资额为人民币1000万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1135561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","BK0197","BK0185","BK0132","BK0250","BK0077","002589"],"gpt_icon":0},{"id":"2438344486","title":"5月28日瑞康医药现1275万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2438344486","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438344486?lang=zh_cn&edition=full","pubTime":"2024-05-28 16:42","pubTimestamp":1716885730,"startTime":"0","endTime":"0","summary":"证券之星消息,5月28日瑞康医药发生大宗交易,交易数据如下:大宗交易成交价格2.55元,相对当日收盘价折价1.54%,成交500万股,成交金额1275万元,买方营业部为方正证券股份有限公司上海杨高南路证券营业部,卖方营业部为民生证券股份有限公司山东第二分公司。近三个月该股共发生3笔大宗交易,合计成交15.3万手,折价成交3笔。截至2024年5月28日收盘,瑞康医药报收于2.59元,下跌0.77%,换手率0.74%,成交量10.07万手,成交额2624.89万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052800029889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0077","BK0132","BK0185","BK0070","BK0250","002589"],"gpt_icon":0},{"id":"2438386752","title":"瑞康医药(002589.SZ)2023年度拟每10股派0.13元 6月4日除权除息","url":"https://stock-news.laohu8.com/highlight/detail?id=2438386752","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438386752?lang=zh_cn&edition=full","pubTime":"2024-05-27 20:09","pubTimestamp":1716811762,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑞康医药(002589.SZ)公告,公司2023年年度拟向全体股东每10股派0.13元(含税),本次权益分派股权登记日为2024年6月3日,除权除息日为2024年6月4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1126705.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0250","BK0197","BK0185","BK0077","BK0132","002589","BK0070"],"gpt_icon":0},{"id":"2437035722","title":"瑞康医药:公司目前无退市风险,公司未来展望详见公司2023年年度报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2437035722","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437035722?lang=zh_cn&edition=full","pubTime":"2024-05-24 20:00","pubTimestamp":1716552037,"startTime":"0","endTime":"0","summary":"证券之星消息,瑞康医药05月24日在投资者关系平台上答复投资者关心的问题。瑞康医药董秘:您好,截止至2024年5月20日,公司股东人数81,203人,感谢您的关注!本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052400042830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0070","BK0250","BK0077","BK0197","BK0185","002589"],"gpt_icon":0},{"id":"2433266363","title":"瑞康医药(002589)5月6日主力资金净卖出246.61万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433266363","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433266363?lang=zh_cn&edition=full","pubTime":"2024-05-07 09:12","pubTimestamp":1715044358,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月6日收盘,瑞康医药报收于2.88元,上涨7.46%,换手率3.77%,成交量51.44万手,成交额1.46亿元。瑞康医药主营业务:公司主营业务分为药品、疫苗、医疗器械流通服务板块,医疗产业第三方物流板块,医疗信息化服务板块,医疗后勤服务板块,中医药板块,医院经营板块,医疗产业研发生产板块,医疗产业金融板块等八大主体板块。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050700012050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0197","BK0250","BK0070","002589","BK0132","BK0077"],"gpt_icon":0},{"id":"2431075988","title":"图解瑞康医药一季报:第一季度单季净利润同比减28.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431075988","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431075988?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:43","pubTimestamp":1714441416,"startTime":"0","endTime":"0","summary":"证券之星消息,瑞康医药2024年一季报显示,公司主营收入20.19亿元,同比下降2.62%;归母净利润1516.9万元,同比下降28.31%;扣非净利润1816.22万元,同比上升526.7%;负债率63.65%,投资收益500.35万元,财务费用5565.88万元,毛利率12.04%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000019386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002589"],"gpt_icon":0},{"id":"2431480586","title":"图解瑞康医药年报:第四季度单季净利润同比增100.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431480586","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431480586?lang=zh_cn&edition=full","pubTime":"2024-04-30 08:36","pubTimestamp":1714437400,"startTime":"0","endTime":"0","summary":"证券之星消息,瑞康医药2023年年报显示,公司主营收入80.34亿元,同比下降34.74%;归母净利润2031.77万元,同比上升101.11%;扣非净利润-2.1亿元,同比上升77.36%;其中2023年第四季度,公司单季度主营收入19.29亿元,同比上升36.39%;单季度归母净利润109.76万元,同比上升100.06%;单季度扣非净利润-1.05亿元,同比上升86.61%;负债率66.26%,投资收益4.09亿元,财务费用1.33亿元,毛利率10.29%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000016210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002589"],"gpt_icon":0},{"id":"2431101038","title":"瑞康医药(002589.SZ)发布一季度业绩,净利润1516.9万元,下降28.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431101038","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431101038?lang=zh_cn&edition=full","pubTime":"2024-04-30 02:24","pubTimestamp":1714415070,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑞康医药(002589.SZ)发布2024年一季度报告,报告期内实现营业收入20.19亿元,同比下降2.62%。归属于上市公司股东的净利润1516.9万元,同比下降28.31%。归属于上市公司股东的扣除非经常性损益的净利润1816.22万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1115914.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002589"],"gpt_icon":0},{"id":"2395385082","title":"瑞康医药(002589.SZ)收到山东证监局警示函","url":"https://stock-news.laohu8.com/highlight/detail?id=2395385082","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2395385082?lang=zh_cn&edition=full","pubTime":"2023-12-29 20:18","pubTimestamp":1703852280,"startTime":"0","endTime":"0","summary":"瑞康医药公告,公司收到山东证监局出具的《关于对瑞康医药集团股份有限公司及相关人员采取出具警示函措施的决定》,现将有关情况公告如下:瑞康医药集团股份有限公司及韩旭、张仁华、冯芸、周云、李喆:经查,你公司存在以下问题:一、未按规定披露关联交易、财务资助等事项;二、未按规定及时披露重大诉讼、仲裁事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-29/doc-imzzsuqw3461273.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-29/doc-imzzsuqw3461273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0185","BK0070","BK0250","BK0132","002589","BK0197","BK0077"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2011-06-10","address":"山东省烟台市芝罘区凤鸣路103号13号楼","stockEarnings":[{"period":"1week","weight":-0.0393},{"period":"1month","weight":-0.0517},{"period":"3month","weight":-0.0973},{"period":"6month","weight":-0.2401},{"period":"1year","weight":-0.3495},{"period":"ytd","weight":-0.3237}],"companyName":"瑞康医药集团股份有限公司","boardCode":"AI0051","perCapita":"11301股","boardName":"批发业","registeredCapital":"150471万元","compareEarnings":[{"period":"1week","weight":0.0023},{"period":"1month","weight":-0.0175},{"period":"3month","weight":-0.0288},{"period":"6month","weight":0.0511},{"period":"1year","weight":-0.0693},{"period":"ytd","weight":0.0007}],"survey":" 瑞康医药集团股份有限公司的主营业务为药品销售。其主要产品和服务为药品和器械配送、体外诊断、数字医疗、医药物流、中医药。公司目前已发展成一家全国性药品、医疗器械流通行业的领军企业之一,在中国医药商业协会公布的最新一期医药流通企业销售排名第七。对医疗机构直销业务规模在全国民营医疗企业中处于领先地位,IVD业务规模在全国处于领先地位。","serverTime":1721381663605,"listedPrice":20,"stockholders":"120698人(较上一季度增加0.23%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑞康医药(002589)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑞康医药(002589)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑞康医药,002589,瑞康医药股票,瑞康医药股票老虎,瑞康医药股票老虎国际,瑞康医药行情,瑞康医药股票行情,瑞康医药股价,瑞康医药股市,瑞康医药股票价格,瑞康医药股票交易,瑞康医药股票购买,瑞康医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑞康医药(002589)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑞康医药(002589)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}